Kazia Therapeutics Ltd
ASX:KZA
Kazia Therapeutics Ltd
Net Income (Common)
Kazia Therapeutics Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kazia Therapeutics Ltd
ASX:KZA
|
Net Income (Common)
-AU$20.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-39%
|
|
Immutep Ltd
ASX:IMM
|
Net Income (Common)
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
Mesoblast Ltd
ASX:MSB
|
Net Income (Common)
-$73.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Net Income (Common)
$2.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Net Income (Common)
AU$30.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Net Income (Common)
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kazia Therapeutics Ltd's Net Income (Common)?
Net Income (Common)
-20.5m
AUD
Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's Net Income (Common) amounts to -20.5m AUD.
What is Kazia Therapeutics Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-39%
Over the last year, the Net Income (Common) growth was 18%. The average annual Net Income (Common) growth rates for Kazia Therapeutics Ltd have been -18% over the past three years , -28% over the past five years , and -39% over the past ten years .